SUBSCRIBE BY RSS rss feed | EMAIL
Natural Solutions Radio header image

Pharmaceutical Industry

Drug trials 'skewed by the pharmaeutical industry,' GPs say

Scientists say controversy surrounding the cholesterol-reducing pills has put patients' health at risk

20 JUNE 2017 • 6:01AM

Four in five GPs believe drug trials are skewed by the pharmaeutical industry, amid widespread mistrust in medical research, polling shows.

A report by the Academy of Medical Sciences is calling for an overhaul of patient information following a string of controversies over the risks and benefits of common drugs.

Schedule II? Cannabis threatens to disrupt the pharmaceutical industry

Here's the kicker: the hardcore killer, Fentanyl, is a Schedule II drug, meaning doctors can prescribe it through pharmacies. Cannabis, on the other hand, which has never killed a soul, is a Schedule I, right up there with heroin.

SSRI drugs based on fabricated medical myths, says psychiatrist

BY Benson: (NaturalNews) The science backing selective serotonin reuptake inhibitors, or SSRIs, as an effective remedy for increasing serotonin levels in the brain and helping depression sufferers achieve mental "balance" is entirely nonexistent, warns a prominent psychiatrist in a new peer-reviewed editorial published in the esteemed British Medical Journal (BMJ).

Vaccines to be made from human cancer tumors

By News Editors:(NaturalNews) (By Sandy Lunoe, published on VacTruth.com.)

Unbelievably, the method of producing vaccines using cells that are derived directly from human cancer tumors has been approved even though the vaccines may induce cancer in recipients. This method is cheaper and faster than breeding animals for the culture media - and human cancer tumors are readily available.

At a meeting of the Food and Drug Administration (FDA) in September 2012, the discussion which led to approval was no less than a scandal. [1]

Monsanto, Dupont, Cargill Spend Big to Defeat GMO Labeling Initiative

The nation's largest agribusiness and biotech companies are pouring millions of dollars into California to stop the first-ever initiative to require special labels on foods made with genetically modified ingredients, a sign of their determination to keep the measure from sparking a nationwide movement.